Christopher L. Reading
Direttore Tecnico/Scientifico/R&S presso Harbor Therapeutics, Inc.
Patrimonio netto: 18 165 $ in data 30/04/2024
Profilo
Christopher L.
Reading is currently the Chief Scientific Officer at Harbor Therapeutics, Inc. He previously held positions as Vice President-Product & Process Development at Systemix, Inc. and Novartis, Inc. He also served as Chief Scientific Officer at Harbor Diversified, Inc. and was an Associate & Assistant Professor at The University of Texas M.D.
Anderson Cancer Center.
Reading holds a doctorate from the University of California, Berkeley and an undergraduate degree from the University of California San Diego.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
BIOVIE INC. CLASS A
0.07% | 16/02/2023 | 37 148 ( 0.07% ) | 18 165 $ | 30/04/2024 |
Posizioni attive di Christopher L. Reading
Società | Posizione | Inizio |
---|---|---|
Harbor Therapeutics, Inc.
Harbor Therapeutics, Inc. BiotechnologyHealth Technology Harbor Therapeutics, Inc. develops a proprietary class of adrenal steroid hormones as novel pharmaceuticals and nutraceuticals for human health. The company is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/1999 |
Precedenti posizioni note di Christopher L. Reading
Società | Posizione | Fine |
---|---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Corporate Officer/Principal | - |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Corporate Officer/Principal | - |
HARBOR DIVERSIFIED, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Christopher L. Reading
University of California, Berkeley | Doctorate Degree |
University of California San Diego | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
HARBOR DIVERSIFIED, INC. | Health Technology |
Aziende private | 4 |
---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
Harbor Therapeutics, Inc.
Harbor Therapeutics, Inc. BiotechnologyHealth Technology Harbor Therapeutics, Inc. develops a proprietary class of adrenal steroid hormones as novel pharmaceuticals and nutraceuticals for human health. The company is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Christopher L. Reading